Feasibility Study of the TGI Adipose-derived Stromal Cell (ASC)-Coated ePTFE Vascular Graft (TGI-PVG-IDE)
A Randomized, Controlled, Parallel Group, Blinded, Feasibility Study of the TGI Adipose-derived Stromal Cell (ASC)-Coated ePTFE Vascular Graft for Femoral-tibial Bypass Grafting.
Sponsor: Tissue Genesis
Listed as NCT01305863, this NA trial focuses on Lower Limb Ischemia and remains ongoing. Sponsored by Tissue Genesis, it has been updated 11 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jul 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Sep 2021 — Jul 2023 [monthly]
Active Not Recruiting NA
-
Feb 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
-
Jun 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Jun 2019 [monthly]
Active Not Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Phase: PHASE1_PHASE2 → NA
-
Feb 2017 — Oct 2017 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE1_PHASE2
First recorded
Feb 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Tissue Genesis
For direct contact, visit the study record on ClinicalTrials.gov .